Edition:
United States

Akers Biosciences Inc (AKER.OQ)

AKER.OQ on NASDAQ Stock Exchange Capital Market

0.40USD
1:56pm EST
Change (% chg)

$0.02 (+6.55%)
Prev Close
$0.38
Open
$0.37
Day's High
$0.42
Day's Low
$0.37
Volume
60,664
Avg. Vol
51,164
52-wk High
$2.85
52-wk Low
$0.36

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy 4.45 December 15 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 0 0 0 0
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.00 1.00 1.00 1.00

Consensus Estimates Analysis

Sales and Profit Figures in British Pound (GBP)
Earnings and Dividend Figures in British Pound (GBP)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 1 1.56 1.56 1.56 --
Year Ending Dec-17 1 3.42 3.42 3.42 --
Year Ending Dec-18 1 8.17 8.17 8.17 --
Earnings (per share)
Quarter Ending Dec-17 1 4.45 4.45 4.45 --
Year Ending Dec-17 1 -25.23 -25.23 -25.23 --
Year Ending Dec-18 1 10.39 10.39 10.39 --

Historical Surprises

Sales and Profit Figures in British Pound (GBP)
Earnings and Dividend Figures in British Pound (GBP)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 1.19 0.51 0.68 56.97
Quarter Ending Jun-17 0.84 0.92 0.08 9.52
Quarter Ending Mar-15 1.26 0.32 0.93 74.22
Quarter Ending Dec-14 0.89 0.97 0.07 8.34
Earnings (per share)
Quarter Ending Sep-17 0.00 -9.88 9.88 0.00
Quarter Ending Jun-17 -3.14 -6.17 3.03 -96.56
Quarter Ending Mar-15 -9.53 -16.52 6.99 -73.30
Quarter Ending Dec-14 -7.15 -44.15 37.00 -517.65

Consensus Estimates Trend

Sales and Profit Figures in British Pound (GBP)
Earnings and Dividend Figures in British Pound (GBP)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 1.56 1.56 1.36 1.36 --
Year Ending Dec-17 3.42 3.42 3.97 3.97 --
Year Ending Dec-18 8.17 8.17 8.40 8.40 --
Earnings (per share)
Quarter Ending Dec-17 4.45 4.45 1.57 1.57 --
Year Ending Dec-17 -25.23 -25.23 -19.38 -19.38 --
Year Ending Dec-18 10.39 10.39 26.69 26.69 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 1 0
Year Ending Dec-17 0 0 0 1
Year Ending Dec-18 0 0 0 1
Earnings
Quarter Ending Dec-17 0 0 1 0
Year Ending Dec-17 0 0 0 1
Year Ending Dec-18 0 0 0 1